BiotechTube
Home/Edgewise Therapeutics/Marc Belsky, J.D.
MB

Marc Belsky, J.D.

Chief Legal Officer & Corporate Secretary

Edgewise Therapeutics

Therapeutic Areas

Muscle DiseasesNeuromuscular Disorders

Edgewise Therapeutics Pipeline

DrugIndicationPhase
EDG-5506Becker Muscular Dystrophy (BMD)Phase 2/3

Leadership Team at Edgewise Therapeutics

KK
Kevin Koch, Ph.D.
President, CEO & Founder
JS
Joel Schneider, Ph.D.
COO & CFO
JT
Joshua T. Brumm, M.B.A.
COO (Strategic Operations)
AR
Alan Russell, Ph.D.
Chief Scientific Officer
SD
Simon Dagenais, Ph.D.
SVP, Development & Head of Clinical Development
View full Edgewise Therapeutics profile